Tridix Bio was founded in 2024 and is headquartered in the biotech hub of San Diego. The company is dedicated to advancing drug development through innovative cell biology technologies. Specializing in cutting-edge organoid generation, primary cell isolation, cell engineering, protein production, assay development, validation, and in vitro screening, Tridix Bio is at the forefront of providing the tools and expertise necessary to accelerate the discovery and development of new therapeutics. Our mission is to empower researchers with the next generation of in vitro platforms, transforming the landscape of drug discovery and disease modeling.